Business news

    Mayne Pharma Group (ASX:MYX) announces cancellation of capital return

    Article Image

    Mayne Pharma Group (ASX:MYX) has announced it's cancelled the proposed pro rata capital return as it is no longer believed to be in the best interests of the company or its shareholders.

    The Board believes it is prudent to retain an appropriate balance sheet to support the business while continuing to assess the appropriate capital structure.

    Mayne Pharma Group says the decision is disappointing to some shareholders, however, the company is confident that the successful execution of its strategy will return the company to profitability and restore value for shareholders.

    The Group's share price closed up almost 19% today. 

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa